AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Read more
AstraZeneca India receives CDSCO approval for Durvalumab in combination with FLOT chemotherapy Read more
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Read more
AstraZeneca gains CDSCO approval to import SZC for treating Hyperkalaemia in adult patients Read more